Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Nivolumab and ipilimumab's trials
INITIATE
Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma
Nivolumab and ipilimumab
Completed
Completed
Phase 2
Open NCT03048474 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
INITIATE · Trial Tracker · ComplyRx
